臨床前のミトラ弁疾患の犬におけるミトラ弁不全エコーカルディオグラフィスコア2によるリスク分層
Tommaso Vezzosi1, Giovanni Grosso1, Liva Vatne2
1Department of Veterinary Sciences, University of Pisa, Pisa, Italy.
Journal of veterinary internal medicine
|August 27, 2025
まとめ
簡略化されたミトラ不全エコーカルディオグラフィ (MINE) スコアは,臨床前ミクロ弁疾患 (MMVD) の犬における心臓リスクを効果的に分層化します. このツールは,より良い管理のために"高度なB2"ケースを特定するのに役立ちます.
科学分野:
- 獣医心臓科
- エコカルディオグラフィー
- 犬の健康
背景:
- 臨床前のミクロマトス弁疾患 (MMVD) は,結果に基づく効果的な心臓リスク分層化がない.
- ミトラル不全エコーカルディオグラフィ (MINE) のスコアは,MMVDの重症度分類のために開発されました.
研究 の 目的:
- 臨床前のMMVDにおける心臓リスク分層のMINEスコアを検証する
- MINEのスコアを簡素化し",高度なB2"のステージを定義します.
主な方法:
- 臨床前MMVDの749頭の犬を対象とした多センターコホート研究.
- コックス比例危険性回帰とカプラン・マイヤー分析を用いた.
- MINEスコアと心臓発作までの時間との関連が評価された.
主要な成果:
- 簡略化されたMINEスコア (左心房と大動脈の比,左心房の終端の透析直径,E波速度) は臨床効果を示した.
- 軽度のMMVDの犬は,中度および重度の症例よりも心臓発作までの平均時間がかなり長かった.
- ステージB2では,重症の症例は,中度および軽症の症例と比較して心臓発作までの平均時間が短かった.
結論:
- 簡略化されたMINEスコアは,臨床前のMMVDのリスク分層化において臨床的に有効である.
- "重症"段階のB2犬は,臨床的意思決定を支援する"高度"のB2として定義できます.
さらに関連する動画
11:50High-frequency High-resolution Echocardiography: First Evidence on Non-invasive Repeated Measure of Myocardial Strain, Contractility, and Mitral Regurgitation in the Ischemia-reperfused Murine Heart
Published on: July 9, 2010
24.3K
08:31A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
4.0K
関連する概念動画
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
37
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
37
01:22Mitral Valve Prolapse II: Assessment and Management
39
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
39
01:23Mitral Regurgitation II: Clinical Features and Diagnostic Tests
50
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
50
01:27Mitral Valve Prolapse I: Introduction
42
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
42
01:22Mitral Stenosis I: Introduction
34
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
34
01:26Mitral Stenosis III: Medical Management
21
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
21